Aimovig

Product manufactured by Amgen Inc

Application Nr Approved Date Route Status External Links
BLA761077 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indication S And Usage Aimovig Is Indicated For The Preventive Treatment Of Migraine In Adults. Aimovig Is A Calcitonin Gene-Related Peptide Receptor Antagonist Indicated For The Preventive Treatment Of Migraine In Adults. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Erenumab

Comments